Wellington Management Group’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,871
Closed -$150K 2100
2022
Q4
$150K Sell
11,871
-51
-0.4% -$2.52K ﹤0.01% 1952
2022
Q3
$1.15M Buy
+11,922
New +$1.36M ﹤0.01% 1626
2022
Q2
Sell
-43,146
Closed -$9.28M 2193
2022
Q1
$9.28M Sell
43,146
-89,686
-68% -$21M ﹤0.01% 1216
2021
Q4
$45.5M Sell
132,832
-24,926
-16% -$9.62M 0.01% 860
2021
Q3
$56.4M Hold
157,758
0.01% 778
2021
Q2
$59.7M Sell
157,758
-82,549
-34% -$30.6M 0.01% 769
2021
Q1
$117M Buy
+240,307
New +$123M 0.02% 562

Other funds holding TIL

Wellington Management Group's TIL Position: Q1 2023 in Review

Wellington Management Group sold out of Instil Bio (TIL) in Q1 2023, closing a stake of 11,871 shares — an estimated $150K sold.

Wellington Management Group first reported a position in TIL in Q1 2021 and held it in 7 quarters. The position peaked at $117M in Q1 2021. 73 funds tracked by Wall St. Rank hold TIL as of Q1 2023.

  • Wellington Management Group reported no remaining Instil Bio position as of Q1 2023 after selling out during the quarter.
  • Wellington Management Group sold 11,871 Instil Bio shares in Q1 2023, an estimated $150K.
  • Wellington Management Group first reported a position in Instil Bio in Q1 2021 and held it in 7 quarters.
  • Wellington Management Group's Instil Bio position peaked at $117M in Q1 2021.
  • 73 funds tracked by Wall St. Rank held Instil Bio as of Q1 2023.

Based on Wellington Management Group's 13F filing for Q1 2023, filed 12 May 2023.